The REDUCE-IT trial (N=8,179), which used 4 g/day of icosapentaenoic acid ethyl ester (Vascepa), reported a higher rate of atrial fibrillation and total bleeding in the omega-3 arm, but that study used a mineral oil placebo now believed to have inflated comparative risk, and the absolute bleeding excess was small [12]
This is because fats and carbohydrates can blunt the release of growth hormone, potentially interfering with the peptides mechanism of action
In clinical trial protocols, retatrutide followed a structured dose-escalation schedule designed to minimise gastrointestinal side effects the most commonly reported adverse effects with this class of medication
Additionally , these models support investigation of how cells regulate structural proteins and extracellular matrix components
Given that implanted chondrocytes are responsible for the generation of new cartilage in the defect site, it is not surprising that the quality of these cells critically affects the reparative results of ACI treatment (Davies and Kuiper, 2019)